Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,566Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8AstraZeneca Canada Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Skin Aging & Challenges
Not Confirmed
arrow
Skin Aging & Challenges
Not Confirmed

Ticagrelor

Brand Name : BRILINTA

Patent Number : 2408596

Filing Date : 2001-05-31

Strength per Unit : 90 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2021-05-31

Date Granted : 2010-12-21

blank

02

arrow
Skin Aging & Challenges
Not Confirmed
arrow
Skin Aging & Challenges
Not Confirmed

Ticagrelor

Brand Name : BRILINTA

Patent Number : 2351709

Filing Date : 1999-12-02

Strength per Unit : 90 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-12-02

Date Granted : 2010-04-06

blank

03

arrow
Skin Aging & Challenges
Not Confirmed
arrow
Skin Aging & Challenges
Not Confirmed

Ticagrelor

Brand Name : BRILINTA

Patent Number : 2296665

Filing Date : 1998-07-15

Strength per Unit : 90 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-07-15

Date Granted : 2008-06-10

blank

04

arrow
Skin Aging & Challenges
Not Confirmed
arrow
Skin Aging & Challenges
Not Confirmed

Ticagrelor

Brand Name : BRILINTA

Patent Number : 2659328

Filing Date : 2007-08-20

Strength per Unit : 90 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2027-08-20

Date Granted : 2015-08-11

blank

05

arrow
Skin Aging & Challenges
Not Confirmed
arrow
Skin Aging & Challenges
Not Confirmed

Ticagrelor

Brand Name : BRILINTA

Patent Number : 2659328

Filing Date : 2007-08-20

Strength per Unit : 60 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2027-08-20

Date Granted : 2015-08-11

blank

06

arrow
Skin Aging & Challenges
Not Confirmed
arrow
Skin Aging & Challenges
Not Confirmed

Ticagrelor

Brand Name : BRILINTA

Patent Number : 2408596

Filing Date : 2001-05-31

Strength per Unit : 60 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2021-05-31

Date Granted : 2010-12-21

blank

07

arrow
Skin Aging & Challenges
Not Confirmed
arrow
Skin Aging & Challenges
Not Confirmed

Ticagrelor

Brand Name : BRILINTA

Patent Number : 2351709

Filing Date : 1999-12-02

Strength per Unit : 60 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2019-12-02

Date Granted : 2010-04-06

blank

08

arrow
Skin Aging & Challenges
Not Confirmed
arrow
Skin Aging & Challenges
Not Confirmed

Ticagrelor

Brand Name : BRILINTA

Patent Number : 2296665

Filing Date : 1998-07-15

Strength per Unit : 60 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2018-07-15

Date Granted : 2008-06-10

blank